Establishment of the Ist International Genetic Reference Panel for FactorV Leiden, human gDNA

被引:11
作者
Gray, Elaine
Hawkins, J. Ross
Morrison, Marion
Hawkins, Malcolm
Byrne, Ed
Kitchen, Steve
Jennings, Ian
Makris, Mike
Preston, F. Eric
Metcalfe, Paul
机构
[1] Natl Inst Biol Stand & Controls, Div Haematol, Potters Bar EN6 3QG, Herts, England
[2] UK NEQAS Blood Coagulat, Sheffield, S Yorkshire, England
[3] Royal Hallamshire Hosp, Sheffield Haemophilia & Trombosis Ctr, Sheffield S10 2JF, S Yorkshire, England
关键词
factor V Leiden; genetic reference materials; genomic DNA; in vitro diagnostics;
D O I
10.1160/TH-05-11-0767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Forty-one laboratories participated in an international collaborative study to assess the suitability of a panel of three genomic DNA samples as the 1(st) International Genetic Reference Panel for the Factor V Leiden (FVL) variant. The code numbers of the materials were 03/254 (FV wild type), 03/260 (FVL homozygote) and 03/248 (FVL heterozygote). The participants evaluated the panel against their in-house controls which were known patient samples and commercial controls. In total, 859 genotype tests were carried out on the panel,with an error rate of 0.7%. The errors were not related to specific samples of the panel or to any specific techniques. The findings of this study have indicated that this panel is suitable to be used as a reference material for genotyping of factor V Leiden. It was therefore recommended that the three genomic DNA samples be established as the 1(st) International Genetic Reference Panel for Factor V Leiden, Human gDNA, 04/224. This recommendation was approved by the Scientific and Standardization Committee (SSC) of the ISTH (International Society on Thrombosis and Haemostasis) in June 2004 and the Expert Committee on Biological Standardization (ECBS) of the World Health Organization (WHO) in November 2004.
引用
收藏
页码:215 / 219
页数:5
相关论文
共 22 条
  • [1] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [2] INTERNATIONAL BIOLOGICAL STANDARDS AND REFERENCE PREPARATIONS .2. PROCEDURES USED FOR PRODUCTION OF BIOLOGICAL STANDARDS AND REFERENCE PREPARATIONS
    CAMPBELL, PJ
    [J]. JOURNAL OF BIOLOGICAL STANDARDIZATION, 1974, 2 (04): : 259 - &
  • [3] Chan LC, 1996, THROMB HAEMOSTASIS, V75, P522
  • [4] STRUCTURE OF THE GENE FOR HUMAN COAGULATION FACTOR-V
    CRIPE, LD
    MOORE, KD
    KANE, WH
    [J]. BIOCHEMISTRY, 1992, 31 (15) : 3777 - 3785
  • [5] Resistance to activated protein C, the FV:Q(506) allele, and venous thrombosis
    Dahlback, B
    Hillarp, A
    Rosen, S
    Zoller, B
    [J]. ANNALS OF HEMATOLOGY, 1996, 72 (04) : 166 - 176
  • [6] MYOCARDIAL-INFARCTION, ARG-506 TO GLN FACTOR-V MUTATION, AND ACTIVATED PROTEIN-C RESISTANCE
    EMMERICH, J
    POIRIER, O
    EVANS, A
    MARQUESVIDAL, P
    ARVEILER, D
    LUC, G
    AIACH, M
    CAMBIEN, F
    [J]. LANCET, 1995, 345 (8945): : 321 - 321
  • [7] HERTZBERG M, 2005, IN PRESS AM J CLIN P
  • [8] Activated protein C resistance as a basis for venous thrombosis
    Hillarp, A
    Zoller, B
    Dahlback, B
    [J]. AMERICAN JOURNAL OF MEDICINE, 1996, 101 (05) : 534 - 540
  • [9] Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries
    Holm, J
    Zoller, B
    Berntorp, E
    Erhardt, L
    Dahlback, B
    [J]. JOURNAL OF INTERNAL MEDICINE, 1996, 239 (03) : 221 - 226
  • [10] A racial difference in the prevalence of the Arg506->Gln mutation
    Hooper, WC
    Dilley, A
    Ribeiro, MJA
    Benson, J
    Austin, H
    Silva, V
    Rawlins, P
    Wenger, NK
    Evatt, BL
    [J]. THROMBOSIS RESEARCH, 1996, 81 (05) : 577 - 581